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Abstract Alterations in grey matter structure and func-
tional connectivity (FC) are pathological features of major
depressive disorder (MDD). However, the relationship be-
tween brain structural and functional impairments in
MDD remains uncertain. Thus, the aim of this study was
to investigate the relationship between alterations in grey
matter volume (GMV) and resting-state global functional
connectivity density (rs-gFCD) in MDD. Forty-five pa-
tients with MDD and 48 healthy controls underwent struc-
tural and resting-state functional magnetic resonance im-
aging (fMRI). GMV and rs-gFCD maps of each subject
were created, and the intergroup differences in these neu-
roimaging metrics were evaluated. Compared to healthy
controls, patients with MDD displayed reduced GMV in
the left insula, putamen, amygdala and hippocampus
(mainly in the limbic system). In contrast, decreased rs-
gFCD was observed in the left postcentral and precentral
gyri, right fusiform gyrus and lingual gyrus (mainly in the
sensory system). Furthermore, we found no significant
correlations between GMV and rs-gFCD in these brain
regions. Finally, overlap ratio analysis demonstrated that
the spatial distribution patterns of intergroup differences
on the GMV and rs-gFCD maps were distinct. Our find-
ings suggest that the presence of distinct spatial distribu-
tion patterns of brain atrophy and global FC impairments
might be pathological features of MDD.
Keywords Major depressive disorder . Greymatter volume .
Functional connectivity density . Magnetic resonance
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Introduction
Major depressive disorder (MDD) is typically characterized
by pervasive and persistent sadness and feelings of helpless-
ness and worthlessness (American Psychiatric Association
2013; Kahn 1975). Over the past decade, this disease has
become the second leading cause of disability worldwide
(Brundtland 2001; Rosenblat et al. 2015). In the last ten years,
due to advances in neuroimaging techniques, many stud-
ies using magnetic resonance imaging (MRI) have ex-
plored the pathological features of MDD in terms of both
structural and functional alterations in the brain. These
studies have provided many key findings that have en-
hanced our understanding of the neurobiology of depres-
sion (Northoff et al. 2011; Phillips et al. 2015; Savitz and
Drevets 2009; Wise et al. 2014).
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Grey matter volume (GMV) and functional connectivity
(FC) can be used in clinical applications as biomarkers of
neuropsychiatric disorders (Ashburner and Friston 2000).
Aberrant GMV has been reported in brain regions of the lim-
bic system in patients with MDD, such as the temporal lobe,
basal ganglia, amygdala, hippocampus, insular cortex and
orbitofrontal cortex (Lorenzetti et al. 2009; Peng et al. 2011;
Stratmann et al. 2014; Zou et al. 2010). In addition, aberrant
FC has been reported in brain regions related to the processing
of emotional, cognitive, sensorimotor and visual information
in MDD, such as in the prefrontal lobe, anterior cingulate
cortex, pre-central gyrus, post-central gyrus, fusiform and lin-
gual gyrus, amygdala, and thalamus, etc. (Iwabuchi et al.
2015; Mulders et al. 2015; Peng et al. 2015; van Tol et al.
2013; Zhang et al. 2015). The aforementioned studies sug-
gested that structural and functional alterations coexisted in
patients with MDD. Because brain structure and functional
organization are internally interactive, it is important to inves-
tigate the relationship between the changes in brain structure
and function inMDD. However, to the best of our knowledge,
few studies have investigated the relationships between the
spatial distribution patterns of GMVand FC alterations.
Voxel-based morphometry (VBM) is an unbiased and data-
driven method to quantify tissue content in the brain
(Ashburner and Friston 2000). This algorithm can segment
brain tissue into grey matter, white matter and cerebral blood
flow components and then register these components in a
common template to compare them voxel by voxel. VBM
has been widely used to identify regional variability in brain
GMV in both healthy subjects and patients with neuropsychi-
atric disorders (Peng et al. 2011; Wang et al. 2014). In con-
trast, functional connectivity density mapping (FCDM) is a
voxel-wise, data-driven method that has been commonly used
to examine the density distribution of whole-brain resting-
state FC (Tomasi and Volkow 2010, 2011b, 2011c), i.e.,
resting-state global functional connectivity density (rs-
gFCD). rs-gFCD has also been referred to as the degree of
centrality (Buckner et al. 2009) or intrinsic connectivity con-
trast (Martuzzi et al. 2011), and brain regions with high rs-
gFCD are considered hubs interconnecting distinct, function-
ally specialized systems. Recent studies showed that rs-gFCD
could be used as a biomarker of neuropsychiatric disorders
(Buckner et al. 2009; Tomasi et al. 2015).
In the current study, using VBM and FCDM techniques,
we investigated the relationships between the spatial distribu-
tion patterns of GMVand rs-gFCD alterations in patients with
MDD. Based on the reports of earlier studies, we hypothe-
sized that patients with MDD shared similar spatial distribu-
tions between altered GMVand rs-gFCD in the limbic system,
while they demonstrated unique spatial distributions of altered
rs-gFCD in the sensory system. We also investigated whether
the brain regions exhibiting altered GMV or rs-gFCD were
correlated with clinical variables.
Materials and methods
Subjects
Patients were recruited from the inpatient and outpatient de-
partments of Tianjin Mental Health Center and Tianjin
Anning Hospital. Healthy controls were recruited from the
local community via advertisements. A total of 93 right-
handed subjects, including 45 patients with depression (19
men, mean age 38.8 ± 13.3 years) and 48 healthy controls
(21 men, mean age 38.6 ± 10.5 years), participated in this
study after providing written informed consent in accordance
with the regulations of the Medical Research Ethics
Committee of Tianjin Medical University. Diagnoses of de-
pression were confirmed by two psychiatrists, using the
Structured Clinical Interview for the DSM-IV (SCID) (First
et al. 1997). The exclusion criteria included significant neuro-
logical or physical diseases, past head injury with loss of con-
sciousness, history of drug or alcohol abuse or dependency,
pregnancy or MRI findings of contraindications. Additional
exclusion criteria for the healthy control subjects were a life-
time history of a psychiatric disorder or having a first-degree
relative with a mood or anxiety disorder. Depression severity
was rated using the Hamilton Depression Rating Scale
(HDRS) (Fleck et al. 2004). Twenty-six patients were taking
selective serotonin reuptake inhibitors (SSRIs) as an antide-
pressant medication (paroxetine, citalopram, or sertraline),
eight patients were taking noradrenergic and specific seroto-
nergic antidepressants (mirtazapine), four patients were taking
a serotonin-noradrenaline reuptake inhibitor (SNRI) as an an-
tidepressant medication (venlafaxine), one patient was taking
a melatonin receptor agonist (agomelatine), two patients were
taking Deanxit, and four patients were using Chinese herbal
medicines. In addition, 8 patients were using mood stabilizers
(valproate or atypical antipsychotics), 6 patients simulta-
neously used two types of antidepressants, and 10 patients
used sedative-hypnotic drugs or anxiolytics (Table 1). The
current medication duration varied from 7 days to 3 months,
and only 2 patients were in complete remission during the
scanning period.
MRI data acquisition
MRI data were acquired using a 3.0 T MR system (Discovery
MR750, General Electric, Milwaukee, WI, USA). Tight but
comfortable foam padding was used tominimize headmotion,
and earplugs were used to reduce scanner noise. Sagittal 3D
T1-weighted images were acquired using a brain volume se-
quence with the following parameters: repetition time
(TR) = 8.2 ms; echo time (TE) = 3.2 ms; inversion time
(TI) = 450 ms; flip angle (FA) = 12°; field of view
(FOV) = 256 mm × 256 mm; matrix =256 × 256; slice thick-
ness = 1 mm, no gap; and 188 sagittal slices. Resting-state
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functional MRI (fMRI) data were acquired using a gradient-
echo single-shot echo planar imaging sequence with the fol-
l o w i n g p a r a m e t e r s : T R / T E = 2 0 0 0 / 4 5 m s ;
FOV = 220 mm × 220 mm; matrix =64 × 64; FA = 90°; slice
thickness = 4 mm; gap =0.5 mm; 32 interleaved transverse
slices; and 180 volumes. All of the subjects were instructed to
keep their eyes closed, relax, move as little as possible, think
of nothing in particular, and not fall asleep during the fMRI
scans.
fMRI data preprocessing
Resting-state fMRI data were preprocessed using SPM8 soft-
ware (http://www.fil.ion.ucl.ac.uk/spm). For each subject, the
first 10 volumes were discarded to allow the signal to attain
equilibrium, while the participants adapted to the scanning
noise. The remaining volumes were corrected for the
acquisition time delay between slices. Realignment was then
performed to correct the motion between time points. The
fMRI data for all of the subjects were within the defined
motion thresholds (i.e., translational and rotational motion of
less than 2 mm and 2°, respectively). We also calculated the
frame-wise displacement (FD), which indexes the volume-to-
volume changes in head position. There was no significant
difference in the mean FD (t = −1.286; P = 0.202) between
the patients (0.087 ± 0.040) and controls (0.099 ± 0.044).
Several nuisance covariates (six motion parameters, their
first-order derivatives, and the average BOLD signals of the
ventricles and white matter) were regressed out of the data.
Recently, global signal regression has been considered a con-
troversial topic in resting-state fMRI analyses (Fox et al. 2009;
Murphy et al. 2009) because global signals have also been
found to reflect neurobiologically important information
(Scholvinck et al. 2010). Thus, we did not remove the global
signal in the fMRI data preprocessing. Recent studies have
reported that the signal spike caused by head motion signifi-
cantly contaminated the final resting-state fMRI results, even
after regressing out the linear motion parameters (Power et al.
2012). Therefore, we further regressed out the spike volumes
when the FD of the specific volume exceeded 0.5. The
datasets were then band-pass filtered over a frequency range
of 0.01 to 0.08 Hz. In the normalization step, individual struc-
tural images were linearly (12 affine parameters) co-registered
with the mean functional image. The structural images were
then segmented and normalized to the Montreal Neurological
Institute (MNI) space using a high-level nonlinear warping
algorithm, according to the diffeomorphic anatomical regis-
tration through exponentiated Lie algebra (DARTEL) tech-
nique (Ashburner 2007). Finally, each filtered functional vol-
ume was nonlinearly transformed in the MNI space using the
deformation parameters of the two co-registration steps and
was resampled into a 3-mm cubic voxel.
GMV calculation
The GMV of each voxel was calculated using the VBM8
toolbox (http://dbm.neuro.uni-jena.de/vbm.html). Structural
MR images were segmented into GM, white matter and
cerebrospinal fluid using the standard segmentation model.
After initial affine registration of the GM concentration map
to the MNI space, GM concentration images were nonlinearly
warped using the DARTEL technique (Ashburner 2007), and
the results were resampled to a voxel size of 1.5 mm × 1.5
mm × 1.5 mm. The relative GMVof each voxel was obtained
by multiplying the GM concentration map by the nonlin-
ear determinants derived from the spatial normalization
step. Finally, the GMV images were smoothed using a
Gaussian kernel of 6 mm × 6 mm × 6 mm full width at
half maximum (FWHM).
Table 1 Demographic and
clinical characteristics of the
subjects enrolled in this study
Characteristics MDD HC Statistics P value
Number of subjects 45 48
Age (years) 38.8 (13.3) 38.6 (10.5) t = 0.062 0.951
Sex ratio (female/male) 26/19 27/21 χ2 = 0.022 0.882
HDRS score 27.8 (10.6) N/A
Illness duration (months) 36.5 (62.0) N/A
Concomitant use of psychopharmacologic drugs N/A
Antidepressants (%) 41/45
Chinese herbal medicines (%) 4/45
Combined with mood stabilizers (%) 8/45
Combined with two antidepressants (%) 6/45
Combined with hypnotic-sedative drugs or
anxiolytics (%)
10/45
Data are shown as means (SD)
HC healthy control subjects, HDRSHamilton Depression Rating Scale,MDDmajor depression disorder patients
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Calculation of rs-gFCD
The rs-gFCD of each voxel was calculated using an in-house
script written on a Linux platform, according to the method
described by Tomasi and Volkow (2010, 2011b, 2011c). We
first computed Pearson’s linear correlations between the time
series of each pair of all of the GM voxels and obtained a
whole-brain FC matrix for each subject. The computation
was constrained within a cerebral GM mask, which was gen-
erated by thresholding (a threshold of 0.2) a prior GM proba-
bility map in SPM8. Pairs of voxels with a correlation coeffi-
cient of r > 0.6 were considered significantly connected. For a
given voxel ×0, rs-gFCD was computed as the number of
functional connections between ×0 and all of the other GM
voxels that satisfied the correlation coefficient threshold (i.e.,
r > 0.6). To confirm whether the correlation threshold would
influence intergroup comparisons, we further calculated the
rs-gFCD using the same process, except for a correlation co-
efficient threshold of r > 0.4. To minimize variability across
subjects, grand mean scaling of rs-gFCD was performed by
dividing the rs-gFCD value of each voxel by the mean rs-
gFCD value of all of the cerebral GM voxels. Finally, the rs-
gFCD maps we r e s pa t i a l l y smoo th ed u s i ng a
6 mm × 6 mm × 6 mm FWHM Gaussian kernel.
Calculation of resting-state functional connectivity (rs-FC)
To investigate the FC that contributed to the intergroup differ-
ences in rs-gFCD, brain regions with significant group differ-
ences in rs-gFCD were defined as seed regions. Then, rs-FC
analysis was performed separately for each seed region. For each
subject, rs-FC was defined as the Pearson’s correlation coeffi-
cient between the mean time course of the seed region and that
of each voxel within the cerebral GM. Then, Fisher’s r-to-z trans-
formation was performed on the rs-FC maps to improve the
normality of the data. Finally, the rs-FC maps were smoothed
using a Gaussian kernel of 6 mm × 6 mm × 6 mm FWHM.
Statistical analysis
First, voxel-wise intergroup comparisons of GMVand rs-gFCD
(with r > 0.6) were performed using a GLM, controlling for age
and sex. Correction for multiple comparisons was performed
using the cluster-level topological false-discovery rate (FDR)
method in SPM8 (Chumbley et al. 2010), considering a corrected
cluster-level threshold ofP < 0.05 and a single-voxel threshold of
P = 0.01. According to a recent study (Eklund et al. 2016), fMRI
cluster-wise inferences disproportionately inflate false-positive
rates if a cluster-defining threshold (CDT) of P = 0.01 is used.
To validate the results, we repeated the voxel-wise intergroup
comparisons of GMV and rs-gFCD using a permutation-based
inference tool for nonparametric statistics (Brandomize^, part of
FSL). The number of permutations was set to 5000, and the
significance threshold was set at P < 0.05 after correcting for
family-wise error (FWE) using the threshold-free cluster en-
hancement (TFCE) option in FSL.
To validate whether the correlation threshold would influence
inter-group comparisons, we further compared inter-group differ-
ences in rs-gFCDwith a correlation coefficient of r > 0.4, andwe
performed inter-group analysis using the same GLM model. In
addition, to exclude the possible effect of head size on rs-gFCD
changes, we repeated the voxel-based rs-gFCD comparisons
with the whole-brain GMVas an additional covariate.
To quantify the similarity between the spatial patterns of func-
tional and structural alterations, we examined the overlap ratio
(OR) of the brain regions displaying significant intergroup dif-
ferences in GMVand rs-gFCD. In addition, to exclude the pos-
sibility that thresholding might influence the OR calculation (for
example, a looser statistical threshold may cause larger OR, vise
versa), a spatial correlation coefficient (SCC) between the T
maps ofGMVand rs-gFCD intergroup comparsions cross voxels
was carried out using Pearson’s correlation analyses.
To test whether the alterations in GMV or rs-gFCD were
correlated with the severity of depressive symptoms, we ex-
tracted the mean GMV or rs-gFCD values of each cluster as
identified by the voxel-based GMV or rs-gFCD comparative
analyses, andwe performed region-of-interest (ROI)-based cor-
relation analyses with the HDRS score. Because most of the
variables were not normally distributed, Spearman’s correlation
coefficients were used, and a significance threshold of P < 0.05
was set. To determine whether there was an association be-
tween GMV and rs-gFCD changes, we performed ROI-based
Spearman’s correlation analyses between the rs-gFCD of each
cluster exhibiting altered rs-gFCD and the GMVof each cluster
exhibiting altered GMV in MDD patients.
For the rs-FC comparison, individuals FC maps were entered
into a random-effects one-sample t-test in a voxel-wise manner
using SPM8. FWE correction with P < 0.05 was used to identify
the brain regions showing significant, positive correlations with
each seed region. Then, a GLM-based two-sample t-test was
performed within the positive rs-FC masks to compare the inter-
group differences in rs-FCwhile controlling for age and sex. The
performance of multiple comparisons was corrected using the
cluster-level topological FDR method (P < 0.05).
Results
Demographic and clinical characteristics
The demographic and clinical characteristics of the partici-
pants are shown in Table 1. There were no significant inter-
group differences in sex (χ2 = 0.022; P = 0.882) or age
(t = 0.062; P = 0.951). The mean total HDRS score was
27.8 ± 10.6, and the mean duration of MDD was
36.5 ± 62.0 months.
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Intergroup differences in GMVand rs-gFCD
Compared with the control group, the MDD patient group
exhibited significantly decreased GMV in the left insula,
putamen, amygdala and hippocampus (cluster size =2270;
peak MNI coordinates: x/y/z = −25.5/4.5/−21; peak
t = −4.1), most of which are components of the limbic
system (Fig. 1) (topological FDR q < 0.05; corrected clus-
ter size 2270 voxels). MDD patients also showed signifi-
cantly decreased rs-gFCD in the left postcentral and
precentral gyri (cluster size =226; peak MNI coordinates:
x/y/z = −54/−9/24; peak t = −4.2), which are ascribed to
the sensorimotor system, and decreased rs-gFCD in the
right fusiform and lingual gyri (cluster size =328; peak
MNI coordinates: x/y/z = 27/−66/−18; peak t = −3.9),
which are ascribed to the visual system (Fig. 2) (topolog-
ical FDR q < 0.05; corrected cluster size 226 voxels).
For nonparametric statistics, the MDD patients showed
significantly decreased rs-gFCD in the left sensorimotor
cortex and bilateral visual cortex (Fig. S1) (P < 0.05,
FWE corrected), which were similar to those in the para-
metric statistics. Despite no significant inter-group differ-
ence, we found a trend towards a significant reduction in
GMV (Fig. S2) (P < 0.06, FWE corrected) in the left
insula, putamen, amygdala and hippocampus, although
the spatial extent was smaller than those in the parametric
statistics.
The distributions of brain regions with decreased rs-
gFCD at the threshold of r > 0.4 were similar to those
observed at the threshold of r > 0.6 (Fig. S3).
Furthermore, the aforementioned brain regions with al-
tered rs-gFCD in MDD patients remained after correcting
for whole-brain GMV (Fig. S4) (topological FDR
q < 0.05; corrected cluster size of at least 215 voxels),
indicating that the altered rs-gFCD in MDD patients could
not be explained by individual variance in global GMV.
We did not find increased GMV or rs-gFCD in any brain
region of the MDD subjects.
Overlap ratio analysis demonstrated that there was no over-
lap (OR =0) between the spatial distributions of the intergroup
differences in GMV and rs-gFCD, and Spatial correlation
analysis also showed there was no statistical correlation
(r = 0.004, P = 0.362) between the spatial distributions in T
maps of GMV and rs-gFCD intergroup differences (Fig. 3),
indicating that the spatial distribution patterns of decreased
GMVand rs-gFCD were distinct in MDD patients.
Intergroup differences in rs-FC
MDD patients showed decreased FC between the right visual
seed and the bilateral visual regions and right sensorimotor
region, compared to the healthy subjects (Fig. 4) (topological
FDR q < 0.05; corrected cluster size 273 voxels). However,
there was no significant intergroup difference in the rs-FC of
the left sensorimotor seed (topological FDR q < 0.05).
Correlation between clinical symptoms and neuroimaging
parameters
In MDD patients, we did not find any statistical correla-
tion between the HDRS scores and the examined metrics
(GMV of limbic regions, Spearman’s rho = −0.055,
P = 0 .721 ; r s -gFCD of sensor imotor reg ions ,
Spearman’s rho = −0.169, P = 0.267; rs-gFCD of visual
regions, Spearman’s rho =0.180, P = 0.238). In addition,
no significant correlation was identified between the de-
crease in GMV in the limbic regions and the decrease in
rs-gFCD in either the sensorimotor regions (Spearman’s
Fig. 1 Brain regions exhibiting
significant differences in GMV
between patients with MDD and
healthy subjects. The coloured bar
represents the t value. GMV, grey
matter volume; MDD, major
depressive disorder
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rho = −0.009; P = 0.953) or the visual regions
(Spearman’s rho =0.064; P = 0.678) in MDD patients.
Discussion
In this study, we found that both GMV and rs-gFCD were
reduced in MDD patients compared to healthy controls. The
reductions in GMV were primarily located in the limbic sys-
tem (i.e., left insula, amygdala, and hippocampus). In contrast,
the decreases in rs-gFCD were primarily located in brain re-
gions participating in the sensory system (i.e., left postcentral
and precentral gyri, right fusiform gyrus, and lingual gyrus).
Furthermore, the spatial distribution exhibiting reduced GMV
did not overlap or correlate with that exhibiting decreased rs-
gFCD. These results indicated that the spatial distribution pat-
terns of decreased GMV and rs-gFCD were distinct in MDD
patients. Finally, no brain regions exhibited statistical correla-
tions of either rs-gFCD or GMV with clinical symptoms.
In the present study, the brain regions with reduced
GMV in patients with MDD were primarily located in
the limbic system. This result was consistent with the
early findings of many previous studies (Lorenzetti et al.
2009; Peng et al. 2011; Stratmann et al. 2014; Zou et al.
2010). We also observed decreased rs-gFCD in the senso-
rimotor and visual cortices in MDD patients. Furthermore,
we found that MDD patients showed decreased FC be-
tween the right visual seed and the bilateral visual regions
and the right sensorimotor region, as compared to the
healthy subjects, which is consistent with the rs-gFCD
findings in this study and provides additional information
about the FC of the visual areas that were impaired in
MDD. However, we did not find significant differences
in FC between the left sensorimotor seed and other brain
voxels, which might have been caused by the failure of
seed-based FC analysis in detecting abundant sub-
threshold changes. Our findings indicate that rs-gFCD
analyses might be more sensitive in detecting the global
FC changes than seed-based FC analysis in cases where
many concurrent subthreshold FC changes are presented.
These findings are consistent with several previous re-
ports, such as decreases in the regional spontaneous neu-
ral activity of the pre- and postcentral gyri in MDD
(Liang et al. 2013), decreases in the amplitude of low-
frequency fluctuation (ALFF) in the right lingual gyrus
(Wang et al. 2012), decreases in rs-FC of the calcarine
cortex (Guo et al. 2013) and lingual gyri (Veer et al.
2010), and decreases in activation of the fusiform gyrus
in response to positive stimuli in MDD patients
(Stuhrmann et al. 2011). Recently, Northoff et al. pro-
posed that the deficit in resting-state activity of the
Fig. 2 Brain regions exhibiting
significant differences in rs-gFCD
between patients with MDD and
healthy subjects. The coloured bar




Fig. 3 The spatial correlation coefficient (SCC) between the T maps of
intergroup differences in GMVand rs-gFCD. rs-gFCD, resting-state glob-
al functional connectivity density; GMV, grey matter volume
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sensorimotor network might be an important biomarker
that reflects the clinical psychomotor symptoms of
MDD, such as psychomotor agitation or retardation
(Northoff 2016a; Northoff 2016b; Vares et al. 2015).
Our finding of decreased rs-gFCD in the sensorimotor
system provides additional evidence for this newly devel-
oped hypothesis. Previous studies have suggested that the
visual system plays a key role in the perception of emo-
tions during the presentation of facial stimuli (Dichter
et al. 2009; Tao et al. 2013) and that functional deficits
in the visual processing system can increase sensitivity to
depression-related stimuli (sad words, sad faces)
(Surguladze et al. 2004; Weniger et al. 2004). Our finding
of decreased rs-gFCD in the visual system also supports
the hypothesis of a deficit in visual network functioning
in MDD patients. Although most of the exiting studies of
rs-FC in MDD did not identify abnormalities of FC in the
visual cortex (Mulders et al. 2015), the most recent study
reported abnormal FCD in the visual cortex in first-epi-
sode, drug-naive adult patients with MDD (Zou et al.
2016), consistent with our findings. The reason for this
difference might be that most previous studies used either
seed-based correlation or independent component analysis
(ICA), while our study employed FCD analysis, which
characterizes rs-FC from the perspective of graph theory.
Thus, these methods might have different sensitivity and
specificity in detecting abnormal FC in MDD.
It should be noted that we did not detect aberrant FC in
brain regions related to emotional and cognitive process-
ing, such as the frontopariental network, attentional net-
work, default mode network, emotional-related network,
etc. (Kaiser et al. 2015; Perrin et al. 2012; Wang et al.
2015). This finding was also inconsistent with a recent
study showing decreased rs-gFCD in the MCC and
increased rs-gFCD in the dorsal visual areas (Zhang
et al. 2015). According to previous studies, several fac-
tors, such as age, sex, genetics, therapeutic agents, acqui-
sition parameters, fluctuations of conscious states and the
selection of different preprocessing strategies, contributed
to individual variability in FCD (Liao et al. 2013; Tomasi
and Volkow 2010, 2011a, 2011d). We postulated that dif-
ferences between the involved subjects might have
accounted for the inconsistencies between our findings
and previous findings (Zhang et al. 2015). For example,
our study included 26 female and 19 male MDD patients,
whereas Zhang’s study included 9 women and 12 men,
creating the opposite sex ratio; moreover, racial differ-
ences might also explain the differences between the find-
ings of our study and those of previous studies (for ex-
ample, all Chinese in the present study while German in
Zhang et al). In addition, several studies have reported
that disease state and illness duration could influence
spontaneous neural activity in the brains of MDD patients
to varying degrees (Guo et al. 2012; Wang et al. 2013). In
our study, the MDD patient group included 7 patients
experiencing first major depressive episodes, 2 patients
were in complete remission, and 36 patients had a persis-
tent depressive illness duration of more than 3 months. In
contrast, all of the subjects in Zhang et al.‘s study were
experiencing acute depressive episodes (Zhang et al.
2015). Moreover, the patients in the present study and
Zhang et al.‘s study were all taking antidepressants, mood
stabilizers or other therapeutic agents, and the differences
in therapeutic agents between the two studies likely ex-
plained the aforementioned different findings to some ex-
tent. Finally, different FC-related techniques might have
their own merits (and/or flaws) in depositing different
aspects of rs-FC. For example, rs-gFCD is a powerful
Fig. 4 Brain regions exhibiting
significant differences in rs-FC of
the right visual region between
patients with MDD and healthy
subjects. The coloured bar
represents the t value. rs-FC,
resting-state functional connec-
tivity; MDD, major depressive
disorder; ROI, region of interest
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data-driven technique for quantifying the FCD of each
brain voxel. This metric is also known as the degree of
centrality (Buckner et al. 2009) or intrinsic connectivity
contrast (Martuzzi et al. 2011), and brain regions with
high rs-gFCD are considered functional hubs that are
highly connected to the rest of the brain. This metric to-
tals the contributions of all of the connected voxels with a
certain voxel, thus having greater sensitivity in detecting
concurrent global FC changes; however, it might also
cover some changes when these connectivities show op-
posite directions (for example, some increase, while
others decrease). This hypothesis was supported by a re-
cent meta-analysis; for example, decreased rs-FC between
the regions of the dorsal attention network (DAN) and
frontopariental network (DMN) but increased rs-FC be-
tween the regions of the DAN and default mode network
(DMN) were shown in MDD, which could theoretically
weaken the detection of rs-gFCD alterations in the DAN
(Kaiser et al. 2015). Because, since then, only 2 studies
(including the present study) have explored the alterations
in rs-gFCD in MDD patients, these findings should be
validated in the future using larger sample sizes across
different populations, illness durations, clinical symptoms
and states, and so on.
Notably, in the present study, we aimed to investigate
the spatial relationships between structural atrophy and
functional disconnection in patients with MDD. The co-
existence of structural and functional brain alterations
may constitute the neural mechanism of MDD, and clar-
ifying this issue could facilitate the identification of
treatment targets for MDD. Moreover, structural alter-
ations are likely to affect functional dynamics, yet per-
sistent functional alterations can induce structural chang-
es by affecting synaptic plasticity. Thus, we previously
hypothesized that patients with MDD might share simi-
lar spatial distributions between altered GMV and
rs-gFCD in some networks, such as the limbic system.
Unexpectedly, in this study, the MDD-related GMV
reduction did not spatially overlap with the MDD-
related rs-gFCD decrease. The distinct spatial distribu-
tion between structure and function in MDD was also
reported by Guo et al., who found that brain regions
exhibiting reduced GMV did not overlap with those
exhibiting altered ALFF (Guo et al. 2014a). Our find-
ings suggest that depression might be associated with
distinct patterns of brain structural and functional im-
pairments, which are characterized by grey matter atro-
phy in the limbic system and a reduction in the global
functional communication of the sensory-related circuits.
However, because of the nature of rs-gFCD in charac-
terizing global functional communication efficiency
(unable to determine which functional connectivity is
changed), we cannot exclude that the functional
connectivity patterns of certain hubs of the limbic sys-
tem are not influenced in MDD. In fact, early studies
showed hypo-connectivity of the hippocampus, amygda-
la and insula in MDD (Kaiser et al. 2015).
We did not find any statistical correlations between the
neuroimaging parameters (GMV or rs-gFCD) and clinical
symptoms. According to previous studies, due to the poor
reproducibility of results across different studies, the rela-
tionships between brain structural and functional alter-
ations and the clinical variables associated with MDD
remain controversial (Cao et al. 2012; Drevets et al.
2008; Dunlop and Mayberg 2014; Dutta et al. 2014;
Gong and He 2015; Graham et al. 2013; Grieve et al.
2013; Guo et al. 2014b; Marchand et al. 2012; Mulders
et al. 2015; Wang et al. 2013; Wolfers et al. 2015). Many
confounding factors, such as differences in social and de-
mographic characteristics within the patient population
(e.g., age at first episode, positive or negative family his-
tory of psychological disorders, sample size, extent of
depressive symptoms, current and chronic medication sta-
tus, neuroimaging techniques, and MRI data processing
methods), might underlie the failure to achieve a consen-
sus on this matter (Dunlop and Mayberg 2014; Dutta et al.
2014; Gong and He 2015; Graham et al. 2013; Mulders
et al. 2015; Wolfers et al. 2015). Because longitudinal
follow-up studies could more comprehensively control
for the aforementioned confounding factors and could dy-
namically characterize the development of the pathologi-
cal features of MDD while providing accurate Bstate^ and
Btrait^ markers for early diagnosis or objective predictors
for personalized treatment of MDD, we recommend large-
sample longitudinal follow-up studies enrolling high risk
cases and first-episode, drug-naive MDD patients and the
use of uniform neuroimaging acquisition and analytical
methods to acquire and analyse the neuroimaging and
clinical data at different time points (such as the time
points of the first episode, remission, and recurrence).
Furthermore, follow-up analyses of the differences in neu-
roimaging data between different treatment outcomes in
MDD patients (to identify non-treatment-resistant or
treatment-resistant depression) should be included.
Some limitations of this study should be noted. First,
the patients were taking antidepressants, mood stabilizers
or other therapeutic agents, and it was previously reported
that structural and functional alterations are likely influ-
enced by these therapeutic agents (Chi et al. 2015; Dusi
et al. 2015; Fang et al. 2015; Greicius et al. 2007).
Unfortunately, this difficult question has not yet been sat-
isfactorily resolved (Greicius et al. 2007; Guo et al. 2011)
because the dosages of different antidepressants cannot be
converted to a uniform equivalent in the same manner as
for antipsychotics, which can be converted to a chlor-
promazine equivalent. Therefore, this variable could not
Brain Imaging and Behavior
be used as a covariate to control for the effects of antide-
pressants. A longitudinal follow-up study enrolling only
first-episode drug-naive MDD patients would be prefera-
ble in the future to control for these confounding factors.
Second, although we found decreased rs-gFCD in the sen-
sorimotor and visual regions of MDD patients, we did not
evaluate the sensorimotor and visual functions of both
MDD and NC subjects, which prevented us from draw-
ing firm conclusions concerning the functional impor-
tance of rs-gFCD abnormalities. Third, many other anal-
yses of both structural and functional organization, such
as cortical thickness and surface area, anatomical connec-
tivity, diffusion quantification, anatomical and functional
network, etc., could be conducted simultaneously to
comprehensively reveal the pathological features of
MDD.
Limitation
According to a recent study (Eklund et al. 2016), fMRI
cluster-wise inferences have disproportionately inflated
false-positive rates if a cluster-defining threshold (CDT) of
P = 0.01 is used. We followed the Reviewer’s suggestion
and performed the statistical analysis with CDT P = 0.001.
Unfortunately, our original results could not pass the multiple
comparison correction.
However, to validate our results, we repeated the voxel-
wise intergroup comparisons of GMV and rs-gFCD using a
permutation-based inference tool for nonparametric statistics
(Brandomize^, part of FSL). The number of permutations was
set at 5000, and the significance threshold was set at P < 0.05
after correcting for family-wise error (FWE) using the
threshold-free cluster enhancement (TFCE) option in FSL.
The results of nonparametric statistics are shown in
Figs. R1 and R2 (please see Figs. S1 and S2 in the
Supplementary Materials). MDD patients showed signifi-
cantly decreased rs-gFCD in the left sensorimotor cortex
and bilateral visual cortex (Fig. R1) (P < 0.05, FWE
corrected), similar to those in the parametric statistics.
Despite a lack of significant inter-group difference, we
found a trend towards a significant reduction in GMV
(Fig. R2) (P < 0.06, FWE corrected) in the left insula,
putamen, amygdala and hippocampus, although the spatial
extent was smaller than those in the parametric statistics.
Conclusion
In summary, our study found that reduced GMV was primar-
ily located in the limbic system, while decreased rs-gFCDwas
primarily located in the sensorimotor and visual systems, and
the spatial distributions exhibiting reduced GMVand rs-gFCD
did not overlap or correlate with each other. Our findings
suggest that depression might be associated with distinct spa-
tial patterns of brain grey matter and global functional com-
munication impairments.
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